Cargando…
Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect
Acute graft-versus-host disease (GvHD) causes significant mortality in patients undergoing allogeneic hematopoietic cell transplantation. Immunosuppressive treatment for GvHD can impair the beneficial graft-versus-leukemia effect and facilitate malignancy relapse. Therefore, novel approaches that pr...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327708/ https://www.ncbi.nlm.nih.gov/pubmed/32675222 http://dx.doi.org/10.3324/haematol.2019.242990 |
_version_ | 1783732148932444160 |
---|---|
author | Haring, Eileen Uhl, Franziska M. Andrieux, Geoffroy Proietti, Michele Bulashevska, Alla Sauer, Barbara Braun, Lukas M. de Vega Gomez, Enrique Esser, Philipp R. Martin, Stefan F. Pfeifer, Dietmar Follo, Marie Schmitt-Graeff, Annette Buescher, Joerg Duyster, Justus Grimbacher, Bodo Boerries, Melanie Pearce, Erika L. Zeiser, Robert Apostolova, Petya |
author_facet | Haring, Eileen Uhl, Franziska M. Andrieux, Geoffroy Proietti, Michele Bulashevska, Alla Sauer, Barbara Braun, Lukas M. de Vega Gomez, Enrique Esser, Philipp R. Martin, Stefan F. Pfeifer, Dietmar Follo, Marie Schmitt-Graeff, Annette Buescher, Joerg Duyster, Justus Grimbacher, Bodo Boerries, Melanie Pearce, Erika L. Zeiser, Robert Apostolova, Petya |
author_sort | Haring, Eileen |
collection | PubMed |
description | Acute graft-versus-host disease (GvHD) causes significant mortality in patients undergoing allogeneic hematopoietic cell transplantation. Immunosuppressive treatment for GvHD can impair the beneficial graft-versus-leukemia effect and facilitate malignancy relapse. Therefore, novel approaches that protect and regenerate injured tissues without impeding the donor immune system are needed. Bile acids regulate multiple cellular processes and are in close contact with the intestinal epithelium, a major target of acute GvHD. Here, we found that the bile acid pool is reduced following GvHD induction in a preclinical model. We evaluated the efficacy of bile acids to protect the intestinal epithelium without reducing anti-tumor immunity. We observed that application of bile acids decreased cytokine-induced cell death in intestinal organoids and cell lines. Systemic prophylactic administration of tauroursodeoxycholic acid (TUDCA), the most potent compound in our in vitro studies, reduced GvHD severity in three different murine transplantation models. This effect was mediated by decreased activity of the antigen presentation machinery and subsequent prevention of apoptosis of the intestinal epithelium. Moreover, bile acid administration did not alter the bacterial composition in the intestine suggesting that its effects are cell-specific and independent of the microbiome. Treatment of human and murine leukemic cell lines with TUDCA did not interfere with the expression of antigen presentation-related molecules. Systemic T-cell expansion and especially their cytotoxic capacity against leukemic cells remained intact. This study establishes a role for bile acids in the prevention of acute GvHD without impairing the graft-versus-leukemia effect. In particular, we provide a scientific rationale for the systematic use of TUDCA in patients undergoing allogeneic hematopoietic cell transplantation. |
format | Online Article Text |
id | pubmed-8327708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-83277082021-08-11 Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect Haring, Eileen Uhl, Franziska M. Andrieux, Geoffroy Proietti, Michele Bulashevska, Alla Sauer, Barbara Braun, Lukas M. de Vega Gomez, Enrique Esser, Philipp R. Martin, Stefan F. Pfeifer, Dietmar Follo, Marie Schmitt-Graeff, Annette Buescher, Joerg Duyster, Justus Grimbacher, Bodo Boerries, Melanie Pearce, Erika L. Zeiser, Robert Apostolova, Petya Haematologica Article Acute graft-versus-host disease (GvHD) causes significant mortality in patients undergoing allogeneic hematopoietic cell transplantation. Immunosuppressive treatment for GvHD can impair the beneficial graft-versus-leukemia effect and facilitate malignancy relapse. Therefore, novel approaches that protect and regenerate injured tissues without impeding the donor immune system are needed. Bile acids regulate multiple cellular processes and are in close contact with the intestinal epithelium, a major target of acute GvHD. Here, we found that the bile acid pool is reduced following GvHD induction in a preclinical model. We evaluated the efficacy of bile acids to protect the intestinal epithelium without reducing anti-tumor immunity. We observed that application of bile acids decreased cytokine-induced cell death in intestinal organoids and cell lines. Systemic prophylactic administration of tauroursodeoxycholic acid (TUDCA), the most potent compound in our in vitro studies, reduced GvHD severity in three different murine transplantation models. This effect was mediated by decreased activity of the antigen presentation machinery and subsequent prevention of apoptosis of the intestinal epithelium. Moreover, bile acid administration did not alter the bacterial composition in the intestine suggesting that its effects are cell-specific and independent of the microbiome. Treatment of human and murine leukemic cell lines with TUDCA did not interfere with the expression of antigen presentation-related molecules. Systemic T-cell expansion and especially their cytotoxic capacity against leukemic cells remained intact. This study establishes a role for bile acids in the prevention of acute GvHD without impairing the graft-versus-leukemia effect. In particular, we provide a scientific rationale for the systematic use of TUDCA in patients undergoing allogeneic hematopoietic cell transplantation. Fondazione Ferrata Storti 2020-07-16 /pmc/articles/PMC8327708/ /pubmed/32675222 http://dx.doi.org/10.3324/haematol.2019.242990 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Haring, Eileen Uhl, Franziska M. Andrieux, Geoffroy Proietti, Michele Bulashevska, Alla Sauer, Barbara Braun, Lukas M. de Vega Gomez, Enrique Esser, Philipp R. Martin, Stefan F. Pfeifer, Dietmar Follo, Marie Schmitt-Graeff, Annette Buescher, Joerg Duyster, Justus Grimbacher, Bodo Boerries, Melanie Pearce, Erika L. Zeiser, Robert Apostolova, Petya Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect |
title | Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect |
title_full | Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect |
title_fullStr | Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect |
title_full_unstemmed | Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect |
title_short | Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect |
title_sort | bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327708/ https://www.ncbi.nlm.nih.gov/pubmed/32675222 http://dx.doi.org/10.3324/haematol.2019.242990 |
work_keys_str_mv | AT haringeileen bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT uhlfranziskam bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT andrieuxgeoffroy bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT proiettimichele bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT bulashevskaalla bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT sauerbarbara bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT braunlukasm bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT devegagomezenrique bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT esserphilippr bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT martinstefanf bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT pfeiferdietmar bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT follomarie bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT schmittgraeffannette bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT buescherjoerg bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT duysterjustus bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT grimbacherbodo bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT boerriesmelanie bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT pearceerikal bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT zeiserrobert bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect AT apostolovapetya bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect |